You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 263 No. 11, March 16, 1990 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Grand Rounds at the Clinical Center of the National Institutes of Health
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (57)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Update on Chronic Granulomatous Diseases of Childhood

Immunotherapy and Potential for Gene Therapy

John I. Gallin, MD; Harry L. Malech, MD

JAMA. 1990;263(11):1533-1537.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SELECTED CASE

A 19-YEAR-OLD black man presented with an autosomal recessive form of chronic granulomatous disease (CGD) of childhood (47-kd cytosol protein deficiency). At age 5 years, he was evaluated for a prolonged febrile illness and was found to have a positive tuberculin skin test. He responded to therapy with isoniazid and ethambutol for presumptive tuberculosis. He did well until age 8 years, when he presented with malaise, fever, and an infiltrate in the upper part of his right lung. Bronchoscopy did not yield a diagnosis. He was treated with broad-spectrum antibacterial therapy without altering his signs and symptoms. An immunologic workup that included a nitroblue tetrazolium dye reduction test indicated a failure of his blood neutrophils to produce superoxide. Subsequent studies confirmed the diagnosis of CGD, as indicated by a failure of his stimulated neutrophils to consume oxygen or produce hydrogen peroxide and by defective in vitro killing of . . . [Full Text PDF of this Article]


Author Affiliations

From the Bacterial Diseases Section, Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, Bethesda, Md.


Footnotes

Reprint requests to Bacterial Diseases Section, Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, Bldg 10, Room 11C103, Bethesda, MD 20892 (Dr Gallin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.